Tech Forum: Advancing Nucleic Acid Therapeutics: Certest Pharma’s Development of Ionizable Lipids, LNP Platforms, and Targeted Delivery Systems.

Sponsored By 

Sponsored by: Certest

In this presentation, we will explore Certest Pharma’s integrated efforts to advance nucleic acid therapeutics through the development of next-generation ionizable lipids, lipid nanoparticle (LNP) platforms, and both passive and active targeting strategies. We will highlight our work in formulation optimization, lyophilization of LNP-based systems, and discuss how our business model supports innovation and collaboration across the RNA therapeutic landscape.

Presentations:

• 9:00 AM - 9:30 AM EDT

  Advancing Nucleic Acid Therapeutics: Certest Pharma’s Development of Ionizable Lipids, LNP Platforms, and Targeted Delivery Systems.
  

  Speaker: Jesus Aznar Morales, MBA (he/him/his) – Certest Biotec
• 9:30 AM - 10:00 AM EDT

  Advancing Nucleic Acid Therapeutics: Certest Pharma’s Development of Ionizable Lipids, LNP Platforms, and Targeted Delivery Systems.
  

  Speaker: Javier Giménez-Warren, PhD – Certest Biotec